2021年5月，印度，新冠疫苗接种者与未接种者中德尔塔变异株的优势情况 - Suppr

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.

作者信息

Thangaraj Jeromie Wesley Vivian, Yadav Pragya, Kumar Cp Girish, Shete Anita, Nyayanit Dimpal A, Rani D Sudha, Kumar Abhinendra, Kumar Muthusamy Santhosh, Sabarinathan R, Saravana Kumar V, Jagadeesan M, Murhekar Manoj

机构信息

National Institute of Epidemiology, R127, TNHB, Ayapakkam, Ambattur, Chennai 600077, India.

ICMR National Institute of Virology, Pune, Maharashtra.

出版信息

J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.08.006. Epub 2021 Aug 6.

DOI:10.1016/j.jinf.2021.08.006

PMID:34364949

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8343391/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/164b/8343391/05b5fb6228f5/gr1_lrg.jpg

相似文献

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.

J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.08.006. Epub 2021 Aug 6.

Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster.

Int J Infect Dis. 2022 Jan;114:62-64. doi: 10.1016/j.ijid.2021.10.053. Epub 2021 Oct 30.

SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.

MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.

Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.

Infect Dis (Lond). 2021 Nov;53(11):876-879. doi: 10.1080/23744235.2021.1945139. Epub 2021 Jun 26.

Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021.

MMWR Morb Mortal Wkly Rep. 2021 Oct 8;70(40):1415-1419. doi: 10.15585/mmwr.mm7040a4.

SARS-CoV-2 Delta Variant among Asiatic Lions, India.

Emerg Infect Dis. 2021 Oct;27(10):2723-2725. doi: 10.3201/eid2710.211500.

A case control study to assess effectiveness of measles containing vaccines in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children.

Hum Vaccin Immunother. 2021 Oct 3;17(10):3316-3321. doi: 10.1080/21645515.2021.1930471. Epub 2021 Jun 15.

Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.

MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1513-1519. doi: 10.15585/mmwr.mm7043e1.

Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152.

J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab154.

Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.

Euro Surveill. 2021 Nov;26(44). doi: 10.2807/1560-7917.ES.2021.26.44.2100977.

引用本文的文献

Clinical characterization, molecular and genomic sequencing analysis of SARS-Cov-2 during second wave at Raigarh, Chhattisgarh, India.

Bioinformation. 2024 Sep 30;20(9):1059-1064. doi: 10.6026/9732063002001059. eCollection 2024.

A data-driven approach to study temporal characteristics of COVID-19 infection and death Time Series for twelve countries across six continents.

BMC Med Res Methodol. 2025 Jan 3;25(1):1. doi: 10.1186/s12874-024-02423-y.

Trajectory of COVID-19 response and management strategy in China: scientific rationale driven strategy adjustments.

Front Med. 2024 Feb;18(1):19-30. doi: 10.1007/s11684-024-1074-6. Epub 2024 Apr 2.

Impact of COVID status and blood group on complications in patients in hemorrhagic shock.

Trauma Surg Acute Care Open. 2024 Mar 22;9(1):e001250. doi: 10.1136/tsaco-2023-001250. eCollection 2024.

Genomic epidemiology of SARS-CoV-2 from Uttar Pradesh, India.

Sci Rep. 2023 Sep 8;13(1):14847. doi: 10.1038/s41598-023-42065-6.

Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves.

J Family Med Prim Care. 2023 Jul;12(7):1298-1302. doi: 10.4103/jfmpc.jfmpc_1809_22. Epub 2023 Jul 14.

Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives.

Chem Sci. 2023 May 3;14(23):6149-6206. doi: 10.1039/d2sc06665c. eCollection 2023 Jun 14.

Immune Response to COVID-19 in India through Vaccination and Natural Infection.

Fortune J Health Sci. 2022;5(3):432-454. doi: 10.26502/fjhs.070. Epub 2022 Jul 29.

SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India.

Front Public Health. 2023 Jan 12;10:1040012. doi: 10.3389/fpubh.2022.1040012. eCollection 2022.

The Delta variant wave in Tunisia: Genetic diversity, spatio-temporal distribution and evidence of the spread of a divergent AY.122 sub-lineage.

Front Public Health. 2023 Jan 4;10:990832. doi: 10.3389/fpubh.2022.990832. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.

作者信息

机构信息

National Institute of Epidemiology, R127, TNHB, Ayapakkam, Ambattur, Chennai 600077, India.

ICMR National Institute of Virology, Pune, Maharashtra.

出版信息

J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.08.006. Epub 2021 Aug 6.

DOI:10.1016/j.jinf.2021.08.006

PMID:34364949

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8343391/

Abstract

摘要

相似文献

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.

J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.08.006. Epub 2021 Aug 6.

Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster.

Int J Infect Dis. 2022 Jan;114:62-64. doi: 10.1016/j.ijid.2021.10.053. Epub 2021 Oct 30.

SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.

MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.

Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.

Infect Dis (Lond). 2021 Nov;53(11):876-879. doi: 10.1080/23744235.2021.1945139. Epub 2021 Jun 26.

Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021.

MMWR Morb Mortal Wkly Rep. 2021 Oct 8;70(40):1415-1419. doi: 10.15585/mmwr.mm7040a4.

SARS-CoV-2 Delta Variant among Asiatic Lions, India.

Emerg Infect Dis. 2021 Oct;27(10):2723-2725. doi: 10.3201/eid2710.211500.

A case control study to assess effectiveness of measles containing vaccines in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children.

Hum Vaccin Immunother. 2021 Oct 3;17(10):3316-3321. doi: 10.1080/21645515.2021.1930471. Epub 2021 Jun 15.

Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.

MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1513-1519. doi: 10.15585/mmwr.mm7043e1.

Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152.

J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab154.

Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.

Euro Surveill. 2021 Nov;26(44). doi: 10.2807/1560-7917.ES.2021.26.44.2100977.

引用本文的文献

Clinical characterization, molecular and genomic sequencing analysis of SARS-Cov-2 during second wave at Raigarh, Chhattisgarh, India.

Bioinformation. 2024 Sep 30;20(9):1059-1064. doi: 10.6026/9732063002001059. eCollection 2024.

A data-driven approach to study temporal characteristics of COVID-19 infection and death Time Series for twelve countries across six continents.

BMC Med Res Methodol. 2025 Jan 3;25(1):1. doi: 10.1186/s12874-024-02423-y.

Trajectory of COVID-19 response and management strategy in China: scientific rationale driven strategy adjustments.

Front Med. 2024 Feb;18(1):19-30. doi: 10.1007/s11684-024-1074-6. Epub 2024 Apr 2.

Impact of COVID status and blood group on complications in patients in hemorrhagic shock.

Trauma Surg Acute Care Open. 2024 Mar 22;9(1):e001250. doi: 10.1136/tsaco-2023-001250. eCollection 2024.

Genomic epidemiology of SARS-CoV-2 from Uttar Pradesh, India.

Sci Rep. 2023 Sep 8;13(1):14847. doi: 10.1038/s41598-023-42065-6.

Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves.

J Family Med Prim Care. 2023 Jul;12(7):1298-1302. doi: 10.4103/jfmpc.jfmpc_1809_22. Epub 2023 Jul 14.

Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives.

Chem Sci. 2023 May 3;14(23):6149-6206. doi: 10.1039/d2sc06665c. eCollection 2023 Jun 14.

Immune Response to COVID-19 in India through Vaccination and Natural Infection.

Fortune J Health Sci. 2022;5(3):432-454. doi: 10.26502/fjhs.070. Epub 2022 Jul 29.

SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India.

Front Public Health. 2023 Jan 12;10:1040012. doi: 10.3389/fpubh.2022.1040012. eCollection 2022.

The Delta variant wave in Tunisia: Genetic diversity, spatio-temporal distribution and evidence of the spread of a divergent AY.122 sub-lineage.

Front Public Health. 2023 Jan 4;10:990832. doi: 10.3389/fpubh.2022.990832. eCollection 2022.

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.

作者信息

机构信息

出版信息

相似文献

引用本文的文献